Related Experiment Video
Updated: Aug 5, 2025

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Practical Guide to Glucocorticoid Induced Hyperglycaemia and Diabetes
Hannah L Barker1, Deborah Morrison2, Andrea Llano2
1Diabetes Department, Gartnavel General Hospital, Glasgow University, 1053 Great Western Road, Glasgow, G12 0YN, UK. hannah.barker@nhs.scot.
Glucocorticoids (steroids) can cause high blood sugar and diabetes. This article reviews current best practices for diagnosing and managing steroid-induced glucose problems in all patients.
Area of Science:
- Endocrinology
- Pharmacology
Background:
- Glucocorticoids are widely used anti-inflammatory drugs.
- A known side effect is abnormal glucose metabolism.
- Existing guidelines address glucocorticoid-induced hyperglycemia and diabetes.
Purpose of the Study:
- To discuss current best clinical practice for managing glucocorticoid-induced dysglycaemia.
- To cover diagnosis, investigations, and ongoing management.
- To address both inpatient and outpatient settings.
Main Methods:
- Review of current clinical guidelines and literature.
- Discussion of diagnostic criteria and investigations.
- Outline of management strategies for inpatient and outpatient settings.
Main Results:
- Glucocorticoid use is linked to various glucose metabolism abnormalities.
- Effective management strategies exist for glucocorticoid-induced dysglycaemia.
- Guidelines provide a framework for best practice.
Conclusions:
- Optimal management of glucocorticoid-induced dysglycaemia requires a systematic approach.
- Early diagnosis and tailored interventions are crucial.
- Adherence to best practices improves patient outcomes.
More Related Videos
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
07:35Author Spotlight: Investigating the Blood Glucose Homeostasis in Murine Brain Using a Cost-Effective Hyperglycemic And Hypoglycemic Clamp Technique
Published on: January 26, 2024
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Oral Hypoglycemic Agents: Glinides
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...